Advertisement

Risk of hepatitis B virus reactivation in patients treated with ibrutinib

Sarah P. Hammond, Kaiwen Chen, Alisha Pandit, Matthew S. Davids, Nicolas C. Issa and Francisco M. Marty

Article Information

Citation 
vol. 131 no. 17 1987-1989
PubMed 

Print ISSN 
Online ISSN 
History 
  • Published online April 26, 2018.

Article Versions


Contributors 
  • Sarah P. Hammond, 1Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA; and 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Kaiwen Chen, 1Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA; and 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Alisha Pandit, 1Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA; and 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Matthew S. Davids, 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Nicolas C. Issa, 1Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA; and 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
  • Francisco M. Marty, 1Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA; and 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output